• Vol. 39 No. 2, 152–153
  • 15 February 2010

Sustained Clinical Efficacy after Repeat Intradetrusor Botulinum Toxin Type A in the Treatment of Neurogenic Detrusor Overactivity

32



0 Citing Article
32 Views
7 Downloads

Download PDF

Despite the introduction of more potent and uroselective antimuscarinic agents, many patients with neurogenic detrusor overactivity still suffer from refractory incontinence. Intradetrusor botulinum toxin injections had been shown to be safe and effective in treating such patients who had failed medical therapy.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.